Delphia (USA)’s Merck MRK Stock Holding History

Delphia (USA)’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,140	Closed	-$237K	–	308
2022 Q4	$237K	Buy	+2,140	New	+$219K	0.27%	164
2022 Q3	–	Sell	-7,142	Closed	-$651K	–	371
2022 Q2	$651K	Buy	+7,142	New	+$633K	0.45%	61

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Delphia (USA)'s MRK Position: Q1 2023 in Review

Delphia (USA) sold out of Merck (MRK) in Q1 2023, closing a stake of 2,140 shares — an estimated $237K sold.

Delphia (USA) first reported a position in MRK in Q2 2022 and held it in 2 quarters. The position peaked at $651K in Q2 2022. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

Delphia (USA) reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
Delphia (USA) sold 2,140 Merck shares in Q1 2023, an estimated $237K.
Delphia (USA) first reported a position in Merck in Q2 2022 and held it in 2 quarters.
Delphia (USA)'s Merck position peaked at $651K in Q2 2022.
3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Delphia (USA)'s 13F filing for Q1 2023, filed 15 May 2023.